ConductScience.org, home

Paper7664288

Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression.

Takahashi S and 7 others. Cancer Res, 1995. Cited by 109 papers, by iCite.

Cite this record

ConductScience Library. Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Papers, record 7664288. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7664288

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression.
PubMed
Journal
Cancer Res
PubMed
Year
1995
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
109
iCite
Relative citation ratio, by iCite
2.99
iCite
Revised in PubMed
2007-11-14
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Takahashi SS
2Shan ALA L
3Ritland SRS R
4Delacey KAK A
5Bostwick DGD G
6Lieber MMM M
7Thibodeau SNS N
8Jenkins RBR B

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chromosome DeletionMajor topic
Chromosomes, Human, Pair 7Major topic
Prostatic NeoplasmsMajor topic
Alleles
Chromosome Mapping
Humans
Male
Polymerase Chain Reaction

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P20 CA58225NCI NIH HHSUnited StatesP20CA058225PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 109 citations.

PMIDTitleJournalYearIn PapersSource
28893045Estimation of Serum Butyryl Cholinesterase in Patients with Oral Squamous Cell Carcinoma: A Cross-Sectional Study.J Clin Diagn Res2017https://conductscience.org/library/papers/28893045PubMed
22514517Acetylcholinesterase involvement in apoptosis.Front Mol Neurosci2012https://conductscience.org/library/papers/22514517PubMed
20945404Fine-mapping of prostate cancer aggressiveness loci on chromosome 7q22-35.Prostate2011https://conductscience.org/library/papers/20945404PubMed
17726745Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer patients.J Zhejiang Univ Sci B2007https://conductscience.org/library/papers/17726745PubMed
16474848ST7-mediated suppression of tumorigenicity of prostate cancer cells is characterized by remodeling of the extracellular matrix.Oncogene2006https://conductscience.org/library/papers/16474848PubMed
15931281Genetics of prostate cancer.Clin Med Res2003https://conductscience.org/library/papers/15931281PubMed
12368209
Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia.
Am J Pathol2002https://conductscience.org/library/papers/12368209PubMed
12192601Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies.Neoplasia2002https://conductscience.org/library/papers/12192601PubMed
12080476Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.Oncogene2002https://conductscience.org/library/papers/12080476PubMed
11159178Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features.Am J Pathol2001https://conductscience.org/library/papers/11159178PubMed
10935466Construction of a high-resolution physical map of the approximate 1-Mb region of human chromosome 7q31.1-q31.2 harboring a putative tumor suppressor gene.Neoplasia1999https://conductscience.org/library/papers/10935466PubMed
10825281Genomewide scan for prostate cancer-aggressiveness loci.Am J Hum Genet2000https://conductscience.org/library/papers/10825281PubMed
10763831Definitive functional evidence for a tumor suppressor gene on human chromosome 7q31.1 neighboring the Fra7G site.Oncogene2000https://conductscience.org/library/papers/10763831PubMed
10551800Changes in levels of normal ML-1 gene transcripts associated with the conversion of human nontumorigenic to tumorigenic phenotypes.Gene Expr1999https://conductscience.org/library/papers/10551800PubMed
10487854Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis).Am J Pathol1999https://conductscience.org/library/papers/10487854PubMed
103296107q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma.Am J Pathol1999https://conductscience.org/library/papers/10329610PubMed
10086342Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines.Oncogene1999https://conductscience.org/library/papers/10086342PubMed
9560199
Epstein-Barr virus growth-transformed cells are converted to malignancy following transfection of a 1.3-kb CATR1 antisense construct independent of a change in the level of c-myc expression followed by a 8;14 chromosomal translocation.
Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9560199PubMed
9520444Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9520444PubMed
9413943Commonly deleted region on the long arm of chromosome 7 in differentiated adenocarcinoma of the stomach.Br J Cancer1997https://conductscience.org/library/papers/9413943PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7664288

GET https://conductscience.org/api/papers/v1/7664288/cited_by?page=2